CSIMarket
 


Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 

Cumulative Panbela Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

PBLA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PBLA Quick Ratio for Trailing Twelve Months Period

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Growth 116.24 % 194.47 % 493.88 % 345.15 % 244.05 %
Y / Y Cash & cash equivalent Growth -29.12 % -89.17 % -93.31 % -60.5 % -8.79 %
Quick Ratio for Trailing Twelve Months Period 0.31 0.46 1.07 2.44 4.01
Total Ranking # 2445 # 2691 # 1765 # 1379 # 1018
Seq. Current Liabilities Growth 24.42 % -1.5 % 28.24 % 37.59 % 69.44 %
Seq. Cash & cash equivalent Growth 307.39 % 36.56 % -62.81 % -65.75 % -37.76 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2023
On the trailing twelve months basis Due to growth in Current Liabilities in the I. Quarter to $10 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.31 below Panbela Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 419 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Panbela Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about PBLA
Quick Ratio PBLA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 420
Sector # 814
S&P 500 # 2007


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
6.95 1.9 0.14
(Sep 30 2021)   (Sep. 30, 2014)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Radius Health inc.  0.86 
Scisparc Ltd   0.86 
Societal Cdmo Inc   0.84 
Thorne Healthtech Inc   0.80 
Protokinetix Incorporated  0.80 
Optinose Inc   0.77 
Johnson and Johnson  0.75 
Nabriva Therapeutics Plc  0.75 
Enochian Biosciences Inc   0.74 
Intercure Ltd   0.74 
Mallinckrodt Plc  0.74 
Zoetis Inc   0.71 
Cumberland Pharmaceuticals Inc   0.71 
Phibro Animal Health Corporation  0.70 
Abbott Laboratories  0.67 
Akebia Therapeutics Inc   0.67 
Mallinckrodt Plc  0.67 
Adamis Pharmaceuticals Corporation  0.66 
Comera Life Sciences Holdings Inc   0.66 
Ani Pharmaceuticals inc  0.64 
Regenerx Biopharmaceuticals inc   0.63 
Emergent Biosolutions Inc   0.63 
Pfizer Inc  0.62 
Opko Health Inc   0.60 
Supernus Pharmaceuticals inc   0.60 
Acer Therapeutics Inc   0.58 
Abvc Biopharma Inc   0.58 
Panbela Therapeutics Inc   0.58 
Medicure Inc   0.58 
Celularity Inc   0.58 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071